WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1632972
PLYMOUTH, MN
Position in VRTX
as of Mar 31, 2026
· filed Apr 8, 2026
Position Value
$18,159,888
-$18,673,798 QoQ
Shares Held
40,668
-49.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 5.090122212113016.ToString("F0")%
Shared 0.ToString("F0")%
None 94.90987778788698.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2024CallValue
$2,371,908
CallShares
5,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $121,469,578 across 107 Biotechnology names. VRTX ranks #2 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
37,596 | $29,048,173 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
40,668 | $18,159,888 | |
| 3 | INCY |
Incyte Corp
|
146,306 | $13,770,320 | |
| 4 | EXEL |
Exelixis, Inc.
|
206,578 | $8,860,130 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
112,375 | $6,348,063 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
19,180 | $3,241,803 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
46,665 | $3,015,958 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,478 | $2,805,115 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,159,888 | 40,668 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $36,833,686 | 81,246 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $28,773,399 | 73,469 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $36,791,773 | 82,641 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $38,877,230 | 80,189 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $32,292,110 | 80,189 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $2,371,908 | 5,100 | Call | Sole | 2024-10-24 | |
| 2024-09-30 | $47,387,466 | 101,891 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $40,128,056 | 85,612 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $34,291,868 | 82,036 | Shares | Sole | 2024-04-15 | |
| 2024-03-31 | $585,214 | 1,400 | Call | Sole | 2024-04-15 | |
| 2023-12-31 | $1,831,005 | 4,500 | Call | Sole | 2024-01-30 | |
| 2023-12-31 | $30,506,577 | 74,975 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $16,548,598 | 47,589 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,488,131 | 9,912 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,080,754 | 9,778 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,799,433 | 9,694 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $3,827,429 | 13,219 | Shares | Sole | 2022-10-17 | |
| 2022-03-31 | $5,969,427 | 22,874 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $4,840,642 | 22,043 | Shares | Sole | 2022-02-08 | |
| 2020-09-30 | $1,883,070 | 6,920 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,619,294 | 12,467 | Shares | Sole | 2020-10-13 | |
| No filing history on record for this holder in this stock. | ||||||